Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / John Blenis
Person

John Blenis

Tracked across 1 events · 6 articles · First seen Aug 20, 2026 · Last active Aug 21, 2026

Sentiment
10
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 10
Tech
Prostate cancer amino acid metabolism resistance study
Weill Cornell Medicine investigators published a preclinical study in Nature Metabolism on August 20, 2026, revealing that prostate cancer cells can rewire amino acid metabolism to override normal cholesterol production controls, potentially fueling hormone therapy…
Impact: Senior author and founder of Elikia Inc.; the study may boost his scientific standing and the company's prospects.
Aug 20, 2026 · 6 articles
Key Actions (1)
20 John Blenis founded company Elikia Inc.Prostate cancer amino acid...
ERGEN INTELLIGENCE
Track John Blenis live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.